Emmanuel Dejean

Chief Executive Officer at Calixar SAS

Consumer Services

Commercial Services

Profile

Emmanuel Dejean is the founder of Calixar SAS, a company founded in 2011.
He currently holds the title of Chairman & Chief Executive Officer at Calixar SAS.
Dr. Dejean has a doctorate degree from Université de Montpellier and an undergraduate degree from Institut National Polytechnique de Grenoble.

Emmanuel Dejean active positions

Companies	Position	Start
Calixar SAS Calixar SAS Miscellaneous Commercial ServicesCommercial Services Calixar SAS provides services for the production, extraction, and purification of functional membrane proteins. It offers protein sequence analysis and design optimization, protein expression/production, extraction/solubilization/purification/stabilization, structural and functionality tests, scale-up, crystallography tests, and 3D structure determination services. The firm provides its services for drug and target, vaccine, and antibody discovery applications. The company was founded by Emmanuel Dejean and Pierre Falson in January 2011 and is headquartered in Lyon, France.	Chief Executive Officer	01/01/2011

All active positions of Emmanuel Dejean

Training of Emmanuel Dejean

Université de Montpellier	Doctorate Degree
Institut National Polytechnique de Grenoble	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Emmanuel Dejean's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Calixar SAS Calixar SAS Miscellaneous Commercial ServicesCommercial Services Calixar SAS provides services for the production, extraction, and purification of functional membrane proteins. It offers protein sequence analysis and design optimization, protein expression/production, extraction/solubilization/purification/stabilization, structural and functionality tests, scale-up, crystallography tests, and 3D structure determination services. The firm provides its services for drug and target, vaccine, and antibody discovery applications. The company was founded by Emmanuel Dejean and Pierre Falson in January 2011 and is headquartered in Lyon, France.	Commercial Services